天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> ACS Applied Bio Materials >>article
ACS Applied Bio Materials

ACS Applied Bio Materials

IF: 4.59
Download PDF

Intraocular and intracranial pressure in glaucoma patients taking acetazolamide.

Published:18 June 2020 DOI: 10.1371/journal.pone.0234690 PMID: 32555666
Allison R Loiselle, Emile de Kleine, Pim van Dijk, Nomdo M Jansonius

Abstract

The alternative mechanical theory of glaucoma, in which an increased pressure difference across the lamina cribrosa (difference between intraocular and intracranial pressure; IOP and ICP), rather than solely an elevated IOP, leads to structural and functional vision loss, is still controversial. If the theory is true, a drug that simultaneously lowers both the IOP and ICP may be ineffective. The aim of this study was to determine how acetazolamide (AAZ; a drug prescribed in glaucoma that aims to lower the IOP) affects both IOP and ICP in glaucoma patients and to compare the magnitude and time course of the induced pressure changes with those of healthy subjects not taking AAZ. IOP and noninvasive ICP (measured through emissions from the ear) were measured in 20 glaucoma patients taking 125 mg of AAZ twice daily. Measurements were taken for 30 minutes before taking the drug and for 2 hours post-ingestion. Comparisons were made with 13 age-similar controls. After 12 hours with no anti-glaucoma medication, AAZ did not further reduce IOP in glaucoma patients compared to controls (P = 0.58) but did reduce ICP compared to controls (P = 0.035), by approximately 4 mmHg. Our findings suggest that there are periods during the day when the pressure difference across the lamina cribrosa is larger in case of AAZ use. Future studies should focus on improving the noninvasive ICP testing, different doses and dosing schedules of AAZ, and the time course of IOP in glaucoma patients not taking AAZ.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Acetazolamide 59-66-5 C4H6N4O3S2 408 suppliers $11.00-$600.00
AAZ-A 154 benzoate 2930845-92-2 C14H20N2O.C7H6O2 - Inquiry

Similar articles

IF:5.9

Benzalkonium Chloride in Glaucoma Medications

Ocular Surface Robert Noecker MD, MBA ,etc Published: 1 July 2011
IF:5.6

The Latest Evidence of Erythropoietin in the Treatment of Glaucoma.

International Journal of Molecular Sciences Ting-Yi Lin, Yi-Fen Lai,etc Published: 16 December 2022
IF:14.3

ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure

Advanced Science Xiuru Cui, Yawei Wang,etc Published: 26 November 2024